Bayer expects dynamic growth with higher profitability in the coming years and is accelerating its transformation
The Pharma Data
MARCH 11, 2021
This includes its collaboration with CureVac, with Bayer assisting the company with the ongoing development, manufacture and supply of its COVID-19 vaccine. Growth is to be driven by leading innovation and strong brands, a further digitalization of the business, and potentially also by bolt-on acquisitions. Speeding up sales growth.
Let's personalize your content